Related Experiment Video
Updated: Jun 5, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Unusual paraneoplastic neurological presentation associated with multiple myeloma
Anik Amin1, Enrique Chiu Han2, Rumyar Ardakani2,3
1Neurology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA anik.amin@utsouthwestern.edu.
Abstract:
Various neurological complications can occur in multiple myeloma. We report a unique paraneoplastic neurological presentation that led to a multiple myeloma diagnosis. A man in his mid-40s experienced a 6-month progressive decline in vision and gait. Examination demonstrated an upper motor neuron pattern, while MRI showed bilateral corticospinal tractopathy and optic neuropathy. Workup led to a diagnosis of multiple myeloma, while other causes (eg, primary central nervous system demyelination, toxic-metabolic, degenerative) were ruled out. Paraneoplastic antibody panels were negative. There was no evidence of leptomeningeal meningitis or compressive lesions. He significantly improved after multiple myeloma treatment. We attribute his unique presentation to a probable paraneoplastic syndrome given the temporal relationships to multiple myeloma diagnosis and treatment. Paraneoplastic neurological syndromes in haematological cancers are often not well-defined, thus requiring both a broad evaluation and awareness of potential connections.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Neural Regulation
Parkinson's Disease: Overview